Tocopherol acetate 6 UNT / ubidecarenone 30 mg Oral Capsule [Q-Gel]
RxNorm 1086838

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1086838 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tocopherol acetate 6 UNT / ubidecarenone 30 mg Oral Capsule [Q-Gel].

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
CoQ-10 30 mg / Vitamin E acetate 6 UNT Oral Capsule [Q-Gel]
AUI:9198990
View
SY
Q-Gel Forte (alpha-tocopherol acetate 6 UNT / ubidecarenone 30 mg) Oral Capsule
AUI:9198989
View
SY
Q-Gel Forte (coenzyme Q10 30 mg / vitamin E acetate 6 UNT) Oral Capsule
AUI:9198991
View
SBD
Tocopherol acetate 6 UNT / ubidecarenone 30 mg Oral Capsule [Q-Gel]
AUI:12359723
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
CoQ-10 30 mg / Vitamin E acetate 6 UNT Oral Capsule [Q-Gel]
(Atom ID: 9198990)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
CoQ-10 30 MG / Vitamin E acetate 6 UNT Oral Capsule [Q-Gel]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1086838
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
9198990
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1086838
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Q-Gel Forte (alpha-tocopherol acetate 6 UNT / ubidecarenone 30 mg) Oral Capsule
(Atom ID: 9198989)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Q-Gel Forte (alpha-tocopherol acetate 6 UNT / ubidecarenone 30 MG) Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1086838
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
9198989
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1086838
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Q-Gel Forte (coenzyme Q10 30 mg / vitamin E acetate 6 UNT) Oral Capsule
(Atom ID: 9198991)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Q-Gel Forte (coenzyme Q10 30 MG / vitamin E acetate 6 UNT) Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1086838
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
9198991
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1086838
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Tocopherol acetate 6 UNT / ubidecarenone 30 mg Oral Capsule [Q-Gel]
(Atom ID: 12359723)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
tocopherol acetate 6 UNT / ubidecarenone 30 MG Oral Capsule [Q-Gel]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1086838
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12359723
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1086838
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1115778} 39625
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{331750} 21406
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1115778} 1236136
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{331750} 21406
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1115778} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{331750} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXTERM FORM
Cap
The RxTerm dose form name for this drug

Patient Education

Vitamin E



[Learn More]


Coenzyme Q10 (PDQ)-Patient Version



[Learn More]


* Please review the disclaimer below.